These results indicate that inhibition of TREM1 can not only improve the short-term cardiac function of MIRI mice but also reduce long-term myocardial fibrosis and improve the prognosis of myocardial remodeling. The gene discussed is TREM1; the disease is Myocardial fibrosis.